Señales en vivo de DCTH | Maximiza tus Ganancias con Getagraph.com

COMPRAR 118039 min ago

@ $4.59

Emitido: 13 feb 2024 @ 09:32

Retorno: 21.13%

Señal anterior: feb 6 - 10:18

Señal anterior: Vender

Retorno: -0.33 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe...

Stats
Volumen de hoy	76 804.00
Volumen promedio	209 447
Capitalización de mercado	136.57M
EPS	$0 ( 2024-03-26 )
Próxima fecha de ganancias	( $-0.430 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.890
ATR14	$0.0110 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Aharon Gil	Buy	26 882	Common Shares
2024-03-19	Salamon Steven A J	Buy	26 882	Common Shares
2024-03-19	Rosalind Advisors, Inc.	Buy	619 946	Pre-funded Warrants
2024-03-18	Rook Martha S.	Buy	125 000	Employee Stock Option (Right to Buy)
2024-03-18	Rook Martha S.	Buy	0

INSIDER POWER
93.93
Last 96 transactions
Buy: 8 343 756 \| Sell: 533 108

Volumen Correlación

Largo: -0.04 (neutral)

Corto: -0.85 (strong negative)

Signal:(32.428) Neutral

Delcath Systems Inc Correlación

10 Correlaciones Más Positivas
META	0.947
JBSS	0.939
MANH	0.938
DSGX	0.937
CIFR	0.933
INOD	0.932
NVCT	0.932
IOAC	0.932
ASO	0.932
LIBY	0.931

10 Correlaciones Más Negativas
NCBS	-0.944
TSHA	-0.922
BWB	-0.915
GSMG	-0.915
IPA	-0.911
ALRS	-0.903
HLIO	-0.902
COFS	-0.901
CYRN	-0.9
GXGX	-0.899

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Delcath Systems Inc Correlación - Moneda/Commodity

-0.27
( neutral )

-0.31
( neutral )

0.00
( neutral )

0.45
( neutral )

-0.41
( neutral )

Delcath Systems Inc Finanzas

Annual	2023
Ingresos:	$2.07M
Beneficio Bruto:	$1.30M (63.05 %)
EPS:	$-2.94

FY	2023
Ingresos:	$2.07M
Beneficio Bruto:	$1.30M (63.05 %)
EPS:	$-2.94

FY	2022
Ingresos:	$2.72M
Beneficio Bruto:	$2.03M (74.77 %)
EPS:	$-4.42

FY	2021
Ingresos:	$3.56M
Beneficio Bruto:	$2.88M (81.13 %)
EPS:	$-8.85

Financial Reports:

No articles found.

Delcath Systems Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.